Zyon Ayni: “We Are in Contact with Governments All Over the World”

Zyon Ayni - TradeArabia

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

Zyon Ayni, Founder and CEO of Code Pharma, explained in an interview for TradeArabia about Codivir, a new medication that fights against COVID-19. Code Pharma claimed that in a successful phase 1 clinical trial, the affected patients were back on their feet in 48 hours with no side effects.

Ayni said: “Codivir showed great success in clinical trials and already has received emergency approvals in different countries for the treatment of coronavirus patients. Our team at Code Pharma are now initiating a multi-country phase 2 study with a larger cohort and has submitted additional emergency approval requests to several affected countries”.

“We are in contact with governments all over the world and expect to get emergency approvals from a substantial number of them by the end of a successful phase II study”, Zyon Ayni added.

More To Explore

Zyon Ayni - ynet
Press

Zyon Ayni’s Code Pharma on ynet TV

Codivir, an antiviral medication against COVID-19, was developed by Code Pharma and its Founder and CEO, Zyon Ayni. Dr. Einat Finkelstein, Chief Scientist of the company,